Abstract
(Int J Obstet Anesth. 2019;39:29–34) Remifentanil patient-controlled analgesia (PCA) has been an analgesic option for labor on several obstetric units for 15 to 20 years. It is not as efficacious as epidural analgesia for providing pain relief during labor, but it is considered to have a satisfactory analgesic effect. However, there have been reports of respiratory arrest in obstetric patients receiving remifentanil PCA. The current investigators routinely offer remifentanil for labor analgesia at their institution. They conducted this retrospective study to determine delivery outcomes in women receiving remifentanil PCA compared with women receiving intramuscular (IM) diamorphine or epidural analgesia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
